Invesco’s Histogen Inc. Common Stock HSTO Stock Holding History

Invesco’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-773	Closed	-$714K	–	3792
2017 Q4	$714K	Buy	773 +710	+1,127%	+$656K	﹤0.01%	3162
2017 Q3	$69K	Buy	+63	New	+$71.6K	﹤0.01%	3619

Other funds holding HSTO

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Invesco's HSTO Position: Q1 2018 in Review

Invesco sold out of Histogen Inc. Common Stock (HSTO) in Q1 2018, closing a stake of 773 shares — an estimated $714K sold.

Invesco first reported a position in HSTO in Q3 2017 and held it in 2 quarters. The position peaked at $714K in Q4 2017. 73 funds tracked by Wall St. Rank hold HSTO as of Q1 2018.

Invesco reported no remaining Histogen Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Invesco sold 773 Histogen Inc. Common Stock shares in Q1 2018, an estimated $714K.
Invesco first reported a position in Histogen Inc. Common Stock in Q3 2017 and held it in 2 quarters.
Invesco's Histogen Inc. Common Stock position peaked at $714K in Q4 2017.
73 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2018.

Based on Invesco's 13F filing for Q1 2018, filed 15 May 2018.